New World Health Organization (WHO) guidelines for the treatment of drug resistant tuberculosis (DR-TB) are shaping as a game changer for the estimated 500,000 people diagnosed with DR-TB each year, ...

Drug-resistant tuberculosis represents a major obstacle to global TB control, with outcomes that consistently fall short of WHO targets. Multidrug-resistant tuberculosis (MDR-TB) and extensively ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

Tuberculosis stands as one of the leading causes of death among young people across the world. Modeling studies suggest that in over 96% of the deadly cases involving children younger than 15 years ...

COPENHAGEN (November 19, 2025)—New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next ...

Please provide your email address to receive an email when new articles are posted on . The CDC, IDSA and other agencies created updated guidance for treating drug-susceptible and drug-resistant TB.

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are ...

A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases. At the Wits Advanced Drug Delivery Platform (WADDP), postdoctoral researcher Dr.

In a recent study published in The Lancet Respiratory Medicine, researchers reported the TB-PRACTECAL clinical trial outcomes, which evaluated the efficacy and safety of oral bedaquiline, linezolid, ...